Creative Medical Technology Holdings (CELZ) Research & Development (2016 - 2025)
Historic Research & Development for Creative Medical Technology Holdings (CELZ) over the last 8 years, with Q3 2025 value amounting to $465154.0.
- Creative Medical Technology Holdings' Research & Development fell 2004.86% to $465154.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 424.81%. This contributed to the annual value of $2.4 million for FY2024, which is 2182.73% up from last year.
- Latest data reveals that Creative Medical Technology Holdings reported Research & Development of $465154.0 as of Q3 2025, which was down 2004.86% from $501261.0 recorded in Q2 2025.
- Creative Medical Technology Holdings' 5-year Research & Development high stood at $5.4 million for Q4 2022, and its period low was $10000.0 during Q1 2022.
- In the last 5 years, Creative Medical Technology Holdings' Research & Development had a median value of $465154.0 in 2025 and averaged $732892.3.
- In the last 5 years, Creative Medical Technology Holdings' Research & Development skyrocketed by 1063643.8% in 2022 and then tumbled by 9349.12% in 2023.
- Over the past 5 years, Creative Medical Technology Holdings' Research & Development (Quarter) stood at $50000.0 in 2021, then soared by 10636.44% to $5.4 million in 2022, then tumbled by 93.49% to $349408.0 in 2023, then surged by 35.04% to $471840.0 in 2024, then dropped by 1.42% to $465154.0 in 2025.
- Its last three reported values are $465154.0 in Q3 2025, $501261.0 for Q2 2025, and $743304.0 during Q1 2025.